According to Zhitong Finance App, China Biopharmaceutical (01177.HK) announced that on July 13, 2026, the company will allocate and issue 102,300 new shares based on the conversion of mandatory convertible bonds due 2028 issued on March 20, 2024.
智通財經·07/13/2026 08:41:03
語音播報
According to Zhitong Finance App, China Biopharmaceutical (01177.HK) announced that on July 13, 2026, the company will allocate and issue 102,300 new shares based on the conversion of mandatory convertible bonds due 2028 issued on March 20, 2024.